Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004425817 | SCV004913900 | uncertain significance | not specified | 2024-02-28 | criteria provided, single submitter | clinical testing | The c.1809C>G (p.S603R) alteration is located in exon 16 (coding exon 16) of the ATP13A5 gene. This alteration results from a C to G substitution at nucleotide position 1809, causing the serine (S) at amino acid position 603 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |